Cargando…
Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up
SMR neurofeedback shows potential as a therapeutic tool for reducing sleep problems. It is hypothesized that SMR neurofeedback trains the reticulo-thalamocortical-cortical circuit involved in sleep-spindle generation. As such, strengthening this circuit is hypothesized to reduce sleep problems. The...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831243/ https://www.ncbi.nlm.nih.gov/pubmed/34585339 http://dx.doi.org/10.1007/s10484-021-09525-z |
_version_ | 1784648462802878464 |
---|---|
author | Krepel, Noralie Egtberts, Tommy Touré-Cuq, Emma Bouny, Pierre Arns, Martijn |
author_facet | Krepel, Noralie Egtberts, Tommy Touré-Cuq, Emma Bouny, Pierre Arns, Martijn |
author_sort | Krepel, Noralie |
collection | PubMed |
description | SMR neurofeedback shows potential as a therapeutic tool for reducing sleep problems. It is hypothesized that SMR neurofeedback trains the reticulo-thalamocortical-cortical circuit involved in sleep-spindle generation. As such, strengthening this circuit is hypothesized to reduce sleep problems. The current study aims to investigate the effectiveness of a home-based device that uses SMR neurofeedback to help reduce sleep problems. Thirty-seven participants reporting sleep problems received the SMR neurofeedback-based program for 40 (n = 21) or 60 (n = 16) sessions. The Pittsburgh Sleep Quality Index (PSQI) and Holland Sleep Disorders Questionnaire (HSDQ) were assessed at baseline, session 20, outtake, and follow-up (FU). Actigraphy measurements were taken at baseline, session 20, and outtake. Significant improvements were observed in PSQI Total (d = 0.78), PSQI Sleep Duration (d = 0.52), HSDQ Total (d = 0.80), and HSDQ Insomnia (d = 0.79). Sleep duration (based on PSQI) increased from 5.3 h at baseline to 5.8 after treatment and 6.0 h. at FU. No effects of number of sessions were found. Participants qualified as successful SMR-learners demonstrated a significantly larger gain in sleep duration (d = 0.86 pre-post; average gain = 1.0 h.) compared to non-learners. The home-based SMR tele-neurofeedback device shows the potential to effectively reduce sleep problems, with SMR-learners demonstrating significantly better improvement. Although randomized controlled trials (RCTs) are needed to further elucidate the specific effect of this device on sleep problems, this is the first home-based SMR neurofeedback device using dry electrodes demonstrating effectiveness and feasibility. |
format | Online Article Text |
id | pubmed-8831243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-88312432022-02-23 Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up Krepel, Noralie Egtberts, Tommy Touré-Cuq, Emma Bouny, Pierre Arns, Martijn Appl Psychophysiol Biofeedback Article SMR neurofeedback shows potential as a therapeutic tool for reducing sleep problems. It is hypothesized that SMR neurofeedback trains the reticulo-thalamocortical-cortical circuit involved in sleep-spindle generation. As such, strengthening this circuit is hypothesized to reduce sleep problems. The current study aims to investigate the effectiveness of a home-based device that uses SMR neurofeedback to help reduce sleep problems. Thirty-seven participants reporting sleep problems received the SMR neurofeedback-based program for 40 (n = 21) or 60 (n = 16) sessions. The Pittsburgh Sleep Quality Index (PSQI) and Holland Sleep Disorders Questionnaire (HSDQ) were assessed at baseline, session 20, outtake, and follow-up (FU). Actigraphy measurements were taken at baseline, session 20, and outtake. Significant improvements were observed in PSQI Total (d = 0.78), PSQI Sleep Duration (d = 0.52), HSDQ Total (d = 0.80), and HSDQ Insomnia (d = 0.79). Sleep duration (based on PSQI) increased from 5.3 h at baseline to 5.8 after treatment and 6.0 h. at FU. No effects of number of sessions were found. Participants qualified as successful SMR-learners demonstrated a significantly larger gain in sleep duration (d = 0.86 pre-post; average gain = 1.0 h.) compared to non-learners. The home-based SMR tele-neurofeedback device shows the potential to effectively reduce sleep problems, with SMR-learners demonstrating significantly better improvement. Although randomized controlled trials (RCTs) are needed to further elucidate the specific effect of this device on sleep problems, this is the first home-based SMR neurofeedback device using dry electrodes demonstrating effectiveness and feasibility. Springer US 2021-09-28 2022 /pmc/articles/PMC8831243/ /pubmed/34585339 http://dx.doi.org/10.1007/s10484-021-09525-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Krepel, Noralie Egtberts, Tommy Touré-Cuq, Emma Bouny, Pierre Arns, Martijn Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up |
title | Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up |
title_full | Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up |
title_fullStr | Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up |
title_full_unstemmed | Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up |
title_short | Evaluation of the URGOnight Tele-neurofeedback Device: An Open-label Feasibility Study with Follow-up |
title_sort | evaluation of the urgonight tele-neurofeedback device: an open-label feasibility study with follow-up |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831243/ https://www.ncbi.nlm.nih.gov/pubmed/34585339 http://dx.doi.org/10.1007/s10484-021-09525-z |
work_keys_str_mv | AT krepelnoralie evaluationoftheurgonightteleneurofeedbackdeviceanopenlabelfeasibilitystudywithfollowup AT egtbertstommy evaluationoftheurgonightteleneurofeedbackdeviceanopenlabelfeasibilitystudywithfollowup AT tourecuqemma evaluationoftheurgonightteleneurofeedbackdeviceanopenlabelfeasibilitystudywithfollowup AT bounypierre evaluationoftheurgonightteleneurofeedbackdeviceanopenlabelfeasibilitystudywithfollowup AT arnsmartijn evaluationoftheurgonightteleneurofeedbackdeviceanopenlabelfeasibilitystudywithfollowup |